Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCentaur Regulatory News (CAU)

  • There is currently no data for CAU

Rule 8.3- REPLACEMENT - Centaur Media Plc

23 Oct 2009 16:54

RNS Number : 3291B
BlackRock Group
23 October 2009
 



FORM 8.3

REPLACEMENT FORM CORRECTS SECTION 2(A) TO ENSURE DERIVATIVE DETAILS ON ROW(3) ARE CORRECTLY DISCLOSED ON ROW (2) INSTEAD.

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the City Code on Takeovers and Mergers)

 

1. KEY INFORMATION

Name of person dealing (Note 1)

BlackRock Group

Company dealt in

Centaur Media Plc

Class of relevant security to which the dealings being disclosed relate (Note 2)

10p Ordinary

Date of dealing

22nd October 2009

2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

 

(a)

Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

 

 

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

7,380,493

5.24%

(2) Derivatives (other than options)

2,473,018

1.76%

(3) Options and agreements to purchase/sell

Total

9,853,511

7.00%

 

(b)

Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

 Class of relevant security:

Long

Short

 

Number

(%)

Number

(%)

(1) Relevant securities 

(2) Derivatives (other than options)

(3) Options and agreements to purchase/sell

Total

 

(c) Rights to subscribe (Note 3)

 Class of relevant security:

Details

3. DEALINGS (Note 4)

 

(a) Purchases and sales 

Purchase/sale 

Number of securities

Price per unit (Note 5)

Purchase

14,298

GBP 0.5351

Derivatives transactions (other than options) 

Product name, e.g. CFD

Long/short (Note 6)

Number of securities (Note 7)

Price per unit (Note 5)

CFD

Long

30,890

GBP 0.5359

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

 

Product name e.g. call option 

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price 

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5) 

 

 (ii) Exercising

 

Product name, e.g. call option

Number of securities 

Exercise price per unit (Note 5)

 

(d) Other dealings (including new securities) (Note 4)

 

Nature of transaction (Note 8) 

Details

Price per unit (if applicable) (Note 5)

OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None……………………………………………………………………

Is a Supplemental Form 8 attached? (Note 9) NO

 

 

Date of disclosure

23rd October 2009

Contact name

Nicola Hylton

Telephone number

020 7743 2621

If a connected EFM, name of offeree/offeror with which connected

N/A

If a connected EFM, state nature of connection (Note 10)

N/A

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETBUBDGGUDGGCX
Date   Source Headline
3rd Apr 20253:00 pmRNSAnnual Report 2024 and Associated Documents
21st Mar 20252:42 pmRNSDirector/PDMR Shareholding
19th Mar 20257:00 amRNSPreliminary results for the year ended 31 Dec 2024
24th Feb 20257:00 amRNSDirector/PDMR Shareholding
5th Feb 20257:00 amRNSDirector Declaration
23rd Jan 20257:00 amRNSDirector/PDMR Shareholding
22nd Jan 202512:00 pmRNSTrading Update
20th Dec 20244:09 pmRNSDirector/PDMR Shareholding
12th Dec 20247:00 amRNSDirectorate Change
21st Nov 20244:01 pmRNSDirector/PDMR Shareholding
21st Oct 20243:26 pmRNSDirector/PDMR Shareholding
10th Oct 20247:05 amRNSDirectorate Change
10th Oct 20247:00 amRNSTrading Update
24th Sep 20247:00 amRNSDirector/PDMR Shareholding
5th Sep 20241:22 pmRNSDirector Declaration
21st Aug 20243:47 pmRNSDirector/PDMR Shareholding
21st Aug 202410:29 amRNSDirector/PDMR Shareholding
21st Aug 20247:00 amRNSDirector/PDMR Shareholding
12th Aug 20247:00 amRNSDirector/PDMR and PCA Shareholding
12th Aug 20247:00 amRNSTRANSFER OF SHARES FROM TREASURY TO EBT AND TVR
2nd Aug 20247:00 amRNSDirector/PDMR Shareholding
1st Aug 20243:56 pmRNSHolding(s) in Company
26th Jul 20247:00 amRNSDirector/PDMR Shareholding
26th Jul 20247:00 amRNSDirector/PDMR Shareholding
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSInterim results for the 6 months ended 30 Jun 2024
23rd Jul 20243:58 pmRNSDirector/PDMR Shareholding
12th Jul 20244:20 pmRNSDirector/PDMR Shareholding - Replacement
18th Jun 20244:13 pmRNSDirector/PDMR Shareholding
5th Jun 20243:55 pmRNSHolding(s) in Company
3rd Jun 20243:55 pmRNSDirector Declaration
22nd May 20244:50 pmRNSDirector/PDMR Shareholding
16th May 202412:07 pmRNSHolding(s) in Company
16th May 20247:00 amRNSCompany Secretary Change
10th May 20247:00 amRNSDirector/PDMR Shareholding
8th May 20242:36 pmRNSResult of AGM
8th May 202412:24 pmGNWForm 8.5 (EPT/RI) - Centaur Media plc
8th May 202410:07 amRNSForm 8.5 (EPT/RI)
7th May 202412:26 pmGNWForm 8.3 - Centaur Media PLC
7th May 202411:36 amRNSForm 8.5 (EPT/RI)
7th May 202411:15 amRNSResponse to Rule 2.8 Announcement
7th May 202411:01 amRNSRule 2.8 Announcement
7th May 202410:14 amGNWForm 8.3 - [CENTAUR MEDIA PLC - 03 05 2024] - (CGAML)
7th May 20247:19 amGNWForm 8.5 (EPT/RI) - Centaur Media plc
2nd May 20243:25 pmGNWForm 8.3 - [CENTAUR MEDIA PLC - 01 05 2024] - (CGAML)
2nd May 202410:50 amRNSForm 8.5 (EPT/RI)
2nd May 20247:37 amGNWForm 8.5 (EPT/RI) - Centaur Media
30th Apr 20249:56 amRNSForm 8.5 (EPT/RI)
29th Apr 202410:22 amRNSForm 8.5 (EPT/RI)
26th Apr 202411:37 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.